Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies.

Cancers (Basel) · 2019 · PMC6895806 · PMID 31653027

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

However, when including trials of both primary and secondary prevention of CVD with a treatment duration of 4 years or more, aspirin use was associated with slightly significant benefit as regards cancer mortality benefit (RR, 0.83; 95% CI, 0.70–0.98) [ 26 ], as previously reported [ 60 , 62 , 63 , 64 ].

also in 1,756 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.